HomeADMA • NASDAQ
Follow
ADMA Biologics Inc
Previous close
$6.74
Day range
$6.51 - $6.76
Year range
$3.06 - $6.76
Market cap
1.51B USD
Avg Volume
3.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 73.90M | 47.86% |
Operating expense | 16.85M | -16.71% |
Net income | -17.64M | -44.25% |
Net profit margin | -23.88 | 2.41% |
Earnings per share | 0.04 | 163.33% |
EBITDA | 16.33M | 496.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 51.35M | -40.65% |
Total assets | 329.18M | -5.53% |
Total liabilities | 193.98M | -1.28% |
Total equity | 135.21M | — |
Shares outstanding | 228.22M | — |
Price to book | 11.23 | — |
Return on assets | 10.49% | — |
Return on capital | 12.25% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -17.64M | -44.25% |
Cash from operations | 17.60M | 338.46% |
Cash from investing | -1.41M | 62.46% |
Cash from financing | -38.99M | -162.15% |
Net change in cash | -22.81M | -144.18% |
Free cash flow | 9.94M | 229.61% |
About
Founded
2004
Headquarters
Website
Employees
624